Episode 123: News on the risk of malformations and developmental impairment among the offspring of male patients under antiseizure medication
This EAN Cast episode delves into the critical risks associated with antiseizure medications (ASMs) in male patients and their potential impact on offspring. Featuring expert Yako Christensen, the discussion examines recent data on ASMs and malformations, neurocognitive impairment, and autism spectrum disorders. It addresses the EMA's warning regarding paternal ASM use and explores conflicting study findings, emphasizing the need for clear methodologies and further international data.Topics in this course:
